Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ESTANASDAQ:INMDNASDAQ:MDXGNASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeESTAEstablishment Labs$43.89-1.1%$36.78$26.56▼$52.41$1.26B0.8476,226 shs278,359 shsINMDInMode$15.16-0.4%$14.33$13.14▼$19.85$958.25M1.951.23 million shs595,953 shsMDXGMiMedx Group$6.29+0.9%$6.50$5.47▼$10.14$936.43M1.76675,108 shs319,320 shsTCMDTactile Systems Technology$10.35+2.2%$10.49$8.61▼$21.10$235.50M0.95256,112 shs124,870 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceESTAEstablishment Labs0.00%+7.23%+18.05%+35.88%+0.37%INMDInMode0.00%+6.80%+2.89%-3.53%-13.30%MDXGMiMedx Group0.00%+5.81%-2.10%-10.98%-7.84%TCMDTactile Systems Technology0.00%+0.10%+2.07%-21.53%-9.45%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationESTAEstablishment Labs1.2447 of 5 stars2.41.00.00.01.32.50.6INMDInMode3.3636 of 5 stars3.13.00.00.03.21.71.9MDXGMiMedx Group3.4441 of 5 stars3.53.00.00.00.63.31.9TCMDTactile Systems Technology3.115 of 5 stars3.01.00.00.01.12.53.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceESTAEstablishment Labs 2.80Moderate Buy$52.4019.39% UpsideINMDInMode 2.13Hold$18.5422.35% UpsideMDXGMiMedx Group 3.00Buy$12.5098.89% UpsideTCMDTactile Systems Technology 2.00Hold$16.0054.59% UpsideCurrent Analyst Ratings BreakdownLatest TCMD, INMD, MDXG, and ESTA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/13/2025ESTAEstablishment LabsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$48.005/16/2025ESTAEstablishment LabsBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$62.005/14/2025ESTAEstablishment LabsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$48.005/7/2025TCMDTactile Systems TechnologyB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold5/6/2025TCMDTactile Systems TechnologyPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$25.00 ➝ $14.004/30/2025INMDInModeBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$29.00 ➝ $24.004/29/2025INMDInModeUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$19.00 ➝ $16.254/29/2025INMDInModeCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$17.00 ➝ $15.004/29/2025INMDInModeBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral4/28/2025INMDInModeBaird R WSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/28/2025INMDInModeRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOutperform ➝ Neutral$22.00 ➝ $16.00(Data available from 7/5/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookESTAEstablishment Labs$166.02M7.65N/AN/A$1.90 per share23.10INMDInMode$394.82M2.43$1.82 per share8.31$10.12 per share1.50MDXGMiMedx Group$348.88M2.66$0.33 per share19.14$1.31 per share4.80TCMDTactile Systems Technology$292.98M0.82$1.11 per share9.36$9.03 per share1.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateESTAEstablishment Labs-$84.60M-$3.10N/AN/AN/A-52.34%-196.25%-26.64%8/5/2025 (Estimated)INMDInMode$181.27M$2.336.508.33N/A44.79%17.17%15.20%7/30/2025 (Estimated)MDXGMiMedx Group$42.42M$0.2722.6419.64N/A11.40%22.70%16.77%7/30/2025 (Estimated)TCMDTactile Systems Technology$16.96M$0.6615.6812.32N/A5.52%8.41%6.10%8/4/2025 (Estimated)Latest TCMD, INMD, MDXG, and ESTA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025MDXGMiMedx Group$0.06N/AN/AN/A$90.79 millionN/A5/7/2025Q1 2025ESTAEstablishment Labs-$0.83-$0.70+$0.13-$0.70$41.15 million$41.38 million5/5/2025Q1 2025TCMDTactile Systems Technology-$0.07-$0.13-$0.06-$0.13$63.48 million$61.27 million4/30/2025Q1 2025MDXGMiMedx Group$0.06$0.06N/A$0.05$86.32 million$88.21 million4/28/2025Q1 2025INMDInMode$0.45$0.31-$0.14$0.26$82.21 million$77.87 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthESTAEstablishment LabsN/AN/AN/AN/AN/AINMDInModeN/AN/AN/AN/AN/AMDXGMiMedx GroupN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioESTAEstablishment Labs5.723.362.05INMDInModeN/A8.737.86MDXGMiMedx Group0.094.704.13TCMDTactile Systems Technology0.114.523.99Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipESTAEstablishment Labs72.91%INMDInMode68.04%MDXGMiMedx Group79.15%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipESTAEstablishment Labs11.09%INMDInMode6.92%MDXGMiMedx Group1.70%TCMDTactile Systems Technology2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableESTAEstablishment Labs1,01828.92 million25.71 millionOptionableINMDInMode48063.21 million58.84 millionOptionableMDXGMiMedx Group870147.70 million145.19 millionOptionableTCMDTactile Systems Technology1,03723.25 million22.67 millionOptionableTCMD, INMD, MDXG, and ESTA HeadlinesRecent News About These CompaniesTCMD Tactile Systems Technology, Inc. - Seeking AlphaJuly 2 at 5:19 PM | seekingalpha.comTactile Systems Technology (NASDAQ:TCMD) investors are sitting on a loss of 76% if they invested five years agoJune 23, 2025 | finance.yahoo.comTwo Sigma Investments LP Sells 31,793 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD)June 9, 2025 | marketbeat.comNew Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer SurvivorsJune 3, 2025 | globenewswire.comTactile Medical to Present at Upcoming Investor Conferences in JuneMay 20, 2025 | globenewswire.comTactile Systems Technology, Inc. (NASDAQ:TCMD) CFO Sells $29,034.74 in StockMay 15, 2025 | insidertrades.comTactile Systems Technology's (NASDAQ:TCMD) Soft Earnings Don't Show The Whole PictureMay 13, 2025 | finance.yahoo.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Director Sells $31,911.00 in StockMay 10, 2025 | insidertrades.comPiper Sandler Downgrades Tactile Systems Technology (TCMD)May 8, 2025 | msn.comAnalysts Have Been Trimming Their Tactile Systems Technology, Inc. (NASDAQ:TCMD) Price Target After Its Latest ReportMay 7, 2025 | finance.yahoo.comWhy Tactile Systems Technology, Inc.’s (TCMD) Stock Is Down 33.21%May 6, 2025 | aaii.comATactile Systems stock tumbles after Q1 missMay 6, 2025 | investing.comTactile Systems downgraded to Neutral from Overweight at Piper SandlerMay 6, 2025 | msn.comTactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call TranscriptMay 5, 2025 | seekingalpha.comWith 81% institutional ownership, Tactile Systems Technology, Inc. (NASDAQ:TCMD) is a favorite amongst the big gunsMay 5, 2025 | uk.finance.yahoo.comTactile Systems Technology (TCMD) Reports Q1 Loss, Lags Revenue EstimatesMay 5, 2025 | zacks.comTactile Systems Technology, Inc. Reports First Quarter 2025 Financial ResultsMay 5, 2025 | globenewswire.comWhat To Expect From Tactile Systems Technology Inc (TCMD) Q1 2025 EarningsMay 3, 2025 | finance.yahoo.comTactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025April 21, 2025 | globenewswire.comTactile Systems Technology: Interesting Devices Company, Need More ClarityApril 7, 2025 | seekingalpha.comThe Returns At Tactile Systems Technology (NASDAQ:TCMD) Aren't GrowingMarch 18, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTCMD, INMD, MDXG, and ESTA Company DescriptionsEstablishment Labs NASDAQ:ESTA$43.89 -0.47 (-1.06%) As of 07/3/2025 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.InMode NASDAQ:INMD$15.16 -0.06 (-0.36%) Closing price 07/3/2025 03:31 PM EasternExtended Trading$15.16 +0.01 (+0.03%) As of 07/3/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.MiMedx Group NASDAQ:MDXG$6.28 +0.06 (+0.88%) Closing price 07/3/2025 03:00 PM EasternExtended Trading$6.16 -0.12 (-1.91%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.Tactile Systems Technology NASDAQ:TCMD$10.35 +0.22 (+2.17%) Closing price 07/3/2025 03:34 PM EasternExtended Trading$10.26 -0.09 (-0.87%) As of 07/3/2025 04:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
